Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024
Provided By PR Newswire
Last update: Aug 28, 2024
The clip-on HYLA™ blood sensor, designed to alert physicians of immediate signs of changes in a patient's clinical condition without the need for intermittent actual blood samples, targets a potential $2.5 billion Point of Care testing and Arterial Blood Gas (ABG) analyzer market.
Read more at prnewswire.com1.085
+0.06 (+6.37%)
NASDAQ:IINNW (11/28/2025, 1:01:19 PM)
0.3399
+0.03 (+11.22%)
Find more stocks in the Stock Screener
